Validation of real-time methylation-specific PCR to determine O 6-methylguanine-DNA methyltransferase gene promoter methylation in glioma

Journal of Molecular Diagnostics

Volumn 10, Issue 4, 2008, Pages 332-337

  Vlassenbroeck, Ilse ^a   Califice, Stéphane ^a   Diserens, Annie Claire ^b   Migliavacca, Eugenia ^c,d   Straub, Josef ^a   Di Stefano, Ivano ^a   Moreau, Fabrice ^a   Hamou, Marie France ^b   Renard, Isabelle ^a   Delorenzi, Mauro ^c,d   Flamion, Bruno ^e   DiGuiseppi, James ^a   Bierau, Katja ^a   Hegi, Monika E ^b,d  

^a OncoMethylome Sciences SA   (Belgium)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^d National Center of Competence in Research in Molecular Oncology   (Switzerland)

^e UNIVERSITY OF NAMUR   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; EPIGENETICS; GENE AMPLIFICATION; GENE ASSIGNMENT; GENE SILENCING; GLIOMA; HUMAN; HUMAN TISSUE; METHYLATION; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY;

EID: 47649131468     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2008.070169     Document Type: Article

References (26)

1. Pegg AE: Repair of O(6)-alkylguanine by alkyltransferases. Mutat Res 2000, 462:83-100
2. Gerson SL: MGMT: its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer 2004, 4:296-307
3. Stojic L, Cejka P, Jiricny J: High doses of SN1 type methylating agents activate DNA damage signaling cascades that are largely independent of mismatch repair. Cell Cycle 2005, 4:473-4777
4. Qian XC, Brent TP: Methylation hot spots in the 5′ flanking region denote silencing of the O6-methylguanine-DNA methyltransferase gene. Cancer Res 1997, 57:3672-3677
5. Watts GS, Pieper RO, Costello JF, Peng YM, Dalton WS, Futscher BW: Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene. Mol Cell Biol 1997, 17:5612-5619
6. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG: Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999, 59:793-797
7. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG: Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000, 343:1350-1354
8. Criniere E, Kaloshi G, Laigle-Donadey F, Lejeune J, Auger N, Benouaich-Amiel A, Everhard S, Mokhtari K, Polivka M, Delattre JY, Hoang-Xuan K, Thillet J, Sanson M: MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities. J Neurooncol 2007, 83:173-179
9. Hegi ME, Diserens AC, Godard S, Dietrich PY, Regli L, Ostermann S, Otten P, Van Melle G, deTribolet N, Stupp R: Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin Cancer Res 2004, 10:1871-1874
10. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R: MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005, 352:997-1003
11. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352:987-996
12. Stupp R, Hegi ME, van den Bent MJ, Mason WP, Weller M, Mirimanoff RO, Cairncross JG: Changing paradigms - an update on the multidisciplinary management of malignant glioma. Oncologist 2006, 11:165-180
13. Everhard S, Kaloshi G, Criniere E, Benouaich-Amiel A, Lejeune J, Marie Y, Sanson M, Kujas M, Mokhtari K, Hoang-Xuan K, Delattre JY, Thillet: MGMT methylation: a marker of response to temozolomide in low-grade gliomas. Ann Neurol 2006, 60:740-743
14. Brandes AA, Tosoni A, Cavallo G, Reni M, Franceschi E, Bonaldi L, Bertorelle R, Gardiman M, Ghimenton C, Iuzzolino P, Pession A, Blatt V, Ermani M: Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study. J Clin Oncol 2006, 24:4746-4753
15. Esteller M, Gaidano G, Goodman SN, Zagonel V, Capello D, Botto B, Rossi D, Gloghini A, Vitolo U, Carbone A, Baylin SB, Herman JG: Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. J Natl Cancer Inst 2002, 94:26-32
16. Esteller M, Corn PG, Baylin SB, Herman JG: A gene hypermethylation profile of human cancer. Cancer Res 2001, 61:3225-3229
17. Laird PW: The power and the promise of DNA methylation markers. Nat Rev Cancer 2003, 3:253-266
18. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW: MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000, 28:E32
19. Mikeska T, Bock C, El-Maarri O, Hubner A, Ehrentraut D, Schramm J, Felsberg J, Kahl P, Buttner R, Pietsch T, Waha A: Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis. J Mol Diagn 2007, 9:1525-1578
20. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, Belinsky SA: Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000, 60:5954-5958
21. Fraley C, Raftery AE: Model-based clustering. Discriminant analysis, and density estimation. J Am Stat Assoc 2002, 97:611-631
22. Fraley C, Raftery AE: MCLUST Version 3 for R: Normal Mixture Modeling and Model-based Clustering. Technical Report no. 504, Department of Statistics, University of Washington, 2006
23. Altman DG: Practical Statistics for Medical Research. London, Chapman & Hall, 1991
24. Ogino S, Kawasaki T, Brahmandam M, Cantor M, Kirkner GJ, Spiegelman D, Makrigiorgos GM, Weisenberger DJ, Laird PW, Loda M, Fuchs CS: Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn 2006, 8:209-217
25. Stupp R, Hegi ME, Gilbert MR, Chakravarti A: Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol 2007, 25:4127-4136
26. Kagan J, Srivastava S, Barker PE, Belinsky SA, Cairns P: Towards clinical application of methylated DNA sequences as cancer biomarkers: a Joint NCI's EDRN and NIST Workshop on Standards. Methods, Assays, Reagents and Tools. Cancer Res 2007, 67:4545-4549